CRISPR Therapeutics AG (CRSP) vs Waystar Holding Corp. (WAY)
A side-by-side comparison of CRISPR Therapeutics AG and Waystar Holding Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRSP
CRISPR Therapeutics AG
$54.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
WAY
Waystar Holding Corp.
$26.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CRSP vs WAY
growth of $100 · dividends reinvested · last 2yCRSP -0.9% (-0.5%/yr)WAY +27.9% (+13.1%/yr)WAY compounded faster over this window
CRSP WAY
CRSP vs WAY: by the numbers
- •CRSP is the larger company ($5.21B vs $5.06B market cap).
- •WAY is profitable (11.18% net margin) while CRSP runs a net loss (-3368.72%).
Metrics side by side
Valuation
| Metric | CRSP | WAY |
|---|---|---|
| P/E ratio | N/A | 37.71 |
| Forward P/E | N/A | 15.81 |
| P/S ratio | 388.91 | 4.20 |
| P/B ratio | 2.98 | 1.27 |
| EV / EBITDA | N/A | 15.10 |
| FCF yield | N/A | 4.86% |
Profitability
| Metric | CRSP | WAY |
|---|---|---|
| Gross margin | -6537.01% | 69.11% |
| Operating margin | -16191.40% | 22.87% |
| Net margin | -3368.72% | 11.18% |
| ROE | -25.83% | 3.38% |
| ROIC | -21.12% | 3.38% |
Growth (annualized)
| Metric | CRSP | WAY |
|---|---|---|
| Revenue CAGR (5Y) | 37.32% | N/A |
| Total return CAGR (5Y) | -11.94% | N/A |
Frequently asked
- Is CRSP or WAY more profitable?
- WAY runs the higher net margin — CRSP at -3368.72% versus WAY at 11.18%.
Go deeper
Dig into the metrics
Waystar P/E ratioCRISPR Therapeutics AG ROEWaystar ROECRISPR Therapeutics AG operating marginWaystar operating marginCRISPR Therapeutics AG revenue growthWaystar revenue growthCRISPR Therapeutics AG free cash flowWaystar free cash flow
CRISPR Therapeutics AG & Waystar appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.